Quimica Magna de Mexico, S.A. de C.V. Warning Letter Details

Summary

Based on limited metadata, this warning letter was issued to Quimica Magna de Mexico, S.A. de C.V., a pharmaceutical manufacturer, on October 15, 2020. While the specific violations cannot be detailed due to unavailable subject line information, the letter indicates FDA regulatory concerns regarding drug manufacturing or compliance practices. The warning falls under FDA's drug product oversight authority, though the specific issuing office and exact violation count are not available in the provided metadata.